In human epidermal growth factor receptor 2 (HER2) + breast cancer, H3K27me3 and H3K4me3 modifications regulate the transcriptional activity of key genes involved in lipid metabolism, contributing to trastuzumab resistance [192]. Here, ERBB2 is linked to breast carcinoma.